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A Quality Improvement Collaborative
to Improve Pediatric Primary
Care Genetic Services
Michael L. Rinke, MD, PhD,a Amy Driscoll, MD,b Natalie Mikat-Stevens, MPH,c Jill Healy, MS,c
Elizabeth Colantuoni, PhD,d Abdallah F. Elias, MD,e Beth A. Pletcher, MD,f Ruth S. Gubernick,
MPH,g Ingrid Larson, MSN, RN,h Wendy K. Chung, MD, PhD,i Beth A. Tarini, MD, MSj

OBJECTIVE: To investigate if a national pediatric primary care quality

abstract

improvement collaborative (QIC) could improve and sustain adherence with
process measures related to diagnosis and management of children with
genetic disorders.
METHODS: Thirteen practices in 11 states from the American Academy of

Pediatrics’ Quality Improvement Innovation Networks participated in a
6-month QIC that included regular educational opportunities, access to
genetic professionals, and performance feedback. The QIC identified 11 aims
related to improving diagnosis and management of children with genetic
disorders. The practices evaluated adherence by reviewing patient records
at baseline, monthly for 6 months (active improvement period), and then
once 6 months after the QIC’s conclusion to check for sustainability. Random
intercept binomial regression models with practice level random intercepts
were used to compare adherence over time for each aim.
RESULTS: During the active improvement period, statistically significant

improvements in adherence were observed for 4 of the 7 aims achieving
minimal data submission levels. For example, adherence improved for family
histories created/maintained at health supervision visits documenting all
components of the family history (6% vs 60%, P < .001), and for patients
with specific genetic disorders who received recommended care (58% vs
85%, P < .001). All 4 of these aims also demonstrated statistically significant
improvements during the sustainability period.
CONCLUSIONS: A national QIC reveals promise in improving and sustaining

adherence with process measures related to the diagnosis and management
of genetic disorders. Future research should focus on patient outcome
measures and the optimal number of aims to pursue in QICs.
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Primary care pediatricians are often
responsible for identifying, referring
patients to specialists for definitive
diagnosis, and then managing the
health care of patients with genetic
disorders.1 Although early diagnosis
and intervention, and continued
health supervision remain crucial
for improved outcomes in patients
with genetic disorders,2–5 many

pediatricians express uncertainty
regarding their ability to care for
this complex and heterogeneous
patient population.1,6 Only 49% of
pediatricians agree that they feel
competent in providing health care
to patients related to genetics.7
Practitioners identify a number
of challenges in diagnosing and
caring for pediatric patients with
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FIGURE 1
Timeline of QIC. PDSA, plan-do-study-act.

genetic disorders,4,5,7–9 including
inadequate time, education, and
genetic-focused resources.10–12
Additionally, many pediatricians
report the inconsistent application
of best-practice recommendations
for a cornerstone of genetic disease
assessment: creating family
histories.7,12–15 Finally, although
many genetic conditions have specific
health supervision guidelines,16–24 it
is unclear how often these guidelines
are followed by pediatricians
or how best to ensure guideline
implementation.
In recent years, quality improvement
collaboratives (QICs) have revealed
success in improving adherence to
guidelines and patient outcomes.25–30
A QIC conducted by the American
Academy of Pediatrics’ (AAP) Quality
Improvement Innovation Networks
(QuIIN) increased the number of
pediatric practices with at least 70%
of newborn screens documented and
communicated to families from 27%
to 67%.28 Other, noncollaborative
based quality improvement studies,
many of which were conducted
in adults, suggest computerized
family history tools can improve
family history creation,31–34 and
standardizing family history practices
leads to improved identification of
patients at increased risk of serious
diseases.32,33,35 It remains unclear if
quality improvement methodology,
and QICs in particular, can improve
both diagnosis and ongoing care
management of patients with genetic
disorders in primary care settings.

We hypothesized that a national
pediatric primary care QIC could
improve adherence with process
measures for diagnosis and care
management of children with genetic
disorders, and sustain these changes
after the QIC’s conclusion.

METHODS
Setting
This quality improvement initiative
was conducted from March 2013
through March 2014 with the AAP’s
QuIIN, a national group of practicing
pediatricians interested in quality
improvement. QuIIN is made up of
over 300 ambulatory care practices
in 46 states, ranging from single
practitioner private practices to
large academic institutions with
over 80 physicians. Participation
in QuIIN projects is voluntary and
projects typically involve 10 to 15
participating practices with 3 to 5
quality improvement aims. A survey
of QuIIN practices was conducted
as a needs-assessment before the
project, suggesting appreciable
variation in care provided to children
with genetic disorders.7 Requests
for participation in this project were
solicited from the QuIIN list serve,
and practices were required to
complete an application on baseline
practice characteristics. All practices
that completed the application
were invited to participate (N = 13).
Participation allowed practitioners
to obtain both continuing medical
education credit and American

Board of Pediatrics Maintenance of
Certification Part IV credit.

Intervention
Figure 1 summarizes the intervention
timeline. First, an expert group
of geneticists, primary care
practitioners, quality improvement
specialists, QuIIN staff, and health
services researchers met for
almost 1 year before the first QIC
learning session to develop quality
improvement aims, measures, and
tools for practices. The group met
twice face to face and held monthly
conference calls during this period.
Based on expert consensus, data
in the literature and the needs
assessment described above,7 the QIC
expert group focused on improving 2
domains of genetic care for children:
(1) diagnosis and (2) management.
As QuIIN previously conducted a
newborn screening QIC,28 this was
not a focus of this project. The 11
aims for this project are described in
Table 1.
Each practice was required to
identify a core improvement team,
led by a physician and including at
least 2 other practice members, who
could be physicians, nurses, or office
staff. Practices collected baseline
data for the QIC aims and completed
preassessments of the current state
of their practice in caring for children
with genetic disorders. In March
2013, core improvement teams
participated in a 2-day, face-to-face
learning session led by the expert
group. This learning session covered
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TABLE 1 Collaborative Aims, Deﬁnitions, and Median Patient Records Reviewed per Practice per Month
Aim

Diagnosis of children with genetic disordersa
Family histories are created/maintained at
health supervision visits documenting all
componentsb
Current family histories are discussed with
patient/family, both positives and negatives
Follow-up plans are documented for patients with
a positive family history or signs of genetic
condition
Patients needing genetic laboratory test or
referred to geneticist or other service are
entered into a registry or referral tracking
mechanism
Management of children with genetic disordersd
Patients with genetic disorders have up to date
age-appropriate health supervision visits
Patients with speciﬁc genetic disorders that have
existing disorder-speciﬁc health supervision
guidelines receive the speciﬁed care16–24

Patients with genetic disorders have next steps of
care and planned follow-up
Patients with genetic disorders who require an
emergency plan to prevent catastrophic illness
have a plan requested from the specialist and
placed in the chart, at least annually
Patients with genetic disorders are offered
genetic services at least initially
Patients with genetic disorders older than 11 y
old receive resources and discussion about
transition to adult care at least annually
Patients with genetic disorders have a discussion
about palliative care at least annually when
appropriate

Numerator

Denominator

Median Records
Reviewed or Patients in
Registry per Practice
per Month (IQR)

Record documentation of family history
including all components

Patients whose records were
reviewed

10 (9–12)

Record documentation that a current
family history was discussed with
patient/family
Record documentation of discussion
with patient/families regarding
follow-up plan
Documentation of patients in registry
or referral tracking mechanism

Patients who complete/update a
family history and whose records
were reviewed
Patients who have a positive family
history or identiﬁed concern and
whose records were reviewed
Patients who required a genetic
laboratory test or referral to
geneticist or other service and
whose records were reviewed

9 (6–10)

Record documentation of patients
receiving age-appropriate health
supervision visits
Record documentation of health
supervision guidelines followed
for patients with speciﬁc genetic
disorders that have existing
disorder-speciﬁc health supervision
guidelines
Record documentation of next steps
of care and planned follow-up at
last visit
Record documentation that an annual
emergency plan was requested
from the specialist and placed in the
record
Record documentation of genetic
services offered to the patient/family
at least initially
Record documentation of discussion
about transition to adult care and
transition resources offered at least
annually
Record documentation of palliative care
discussion at least annually when
appropriate for the patient

Patients with deﬁned genetic
disorders entered into the clinic’s
registrye
Patients with deﬁned genetic
disorders entered into the clinic’s
registrye

94.5 (31–235.75)

Patients with deﬁned genetic
disorders entered into the clinic’s
registry
Patients with deﬁned genetic
disorders entered into the clinic’s
registrye

94.5 (31–235.75)

Patients with deﬁned genetic
disorders entered into the clinic’s
registry
Patients with deﬁned genetic
disorders entered into the clinic’s
registry older than 11 y old

94.5 (31–235.75)

Patients with deﬁned genetic
disorders entered into the clinic’s
registrye

0c (0–2)

3c (1–8)

0c (0–1)

16 (2.75–32)

3c (0–7)

30 (5.75–63.25)

IQR, interquartile range.
a All numerators and denominators involved patients 0 to 21 y old seen for health supervision visits.
b Required family history components included discussion and documentation of the following: (1) parents, siblings, aunts/uncles, ﬁrst cousins, and grandparents; (2) medical conditions
present in 2 or more family members; (3) ethnicity; (4) consanguinity; (5) any caregiver/patient concerns about family history; (6) incomplete knowledge of family history (eg, adoptions,
estrangement, etc); and (7) speciﬁc questions about family members with: birth defects, cancer (<50 y old), carriers of genetic disorders, blood disorders, developmental delay, intellectual
disability, early death (<50 y old), heart attack <55 y old for men and <65 y old for women, known genetic condition, multiple miscarriages/stillbirths, special education services, and
seizures.
c These aims were excluded from ﬁnal analyses because the median number of records reviewed or patients include in registries was <5 per practice per month.
d All numerators and denominators involved patients 0 to 21 y old.
e Practices were encouraged to use a predeﬁned list of ICD-9 genetic disorders (Supplemental Information) but could create a local version pertinent to their clinic setting. They reported
on the number of these patients who met collaborative aims each month, regardless if they were seen in clinic that month.

the rationale behind this project,
quality improvement methodology,
genetic knowledge for practitioners,
collaborative team sharing of current
successes and challenges, tools to
improve processes of care, family

history evaluation practice sessions,
and time for teams to develop local
tests of change and 60- to 90-day
aim statements. Additionally, the
QIC partnered with the Genetics
and Newborn Screening Regional

Collaboratives (RCs) to increase
partnership between practices
and genetic professionals at the
community level. Each RC identified a
local genetic professional (geneticist
or genetic counselor) to support
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and mentor each of the participating
practices around the provision of
genetic services.
During the 6-month active
improvement phase, teams
participated in monthly QIC
webinars, phone or e-mail contact
with their RC genetic mentor, data
collection, and data feedback on
how the practice was performing.
Teams could also access an e-mail list
serve to ask questions or solicit best
practices. Teams then participated in
a second face-to-face learning session
on similar topics as the first learning
session, as well as on sustainability
and the project’s overall impact
on patients across practices. After
the second learning session, teams
were no longer exposed to QIC
interventions, although the list serve
remained open but with appreciably
less activity. In March 2014, 6 months
after the second learning session,
teams were asked to submit a final
round of sustainability data.
This project was approved by the
AAP’s institutional review board.

Data Collection
Data were collected through the
AAP’s Quality Improvement Data
Aggregator, a web-based data
collection and analysis program
for QICs, and SurveyMonkey. Both
electronic and paper record review
methodology were used to collect
local data, based on the functionality
of each practice’s electronic health
record. For the 4 aims related to the
diagnosis of children with genetic
disorders, adherence was measured
by the presence of specific items
within patient records, both paperbased and electronic, such as the
use of all predefined components of
a multigenerational family history.
Practices were instructed to review
the first 10 patient records meeting
inclusion criteria in a given month
and no limitations were put on the
number of records per provider
or per clinic location reviewed.
Practices were able to enter more

or less than 10 records monthly. For
some aims, inclusion criteria for the
aim were dependent on the record
successfully meeting the previous
aim. For example, to be eligible for
the aim, “Current family histories are
discussed with patient/family, both
positives and negatives,” the record
had to achieve “Family histories
are created/maintained at health
supervision visits documenting all
components” at that visit.
For the 7 aims related to the
management of children with genetic
disorders, the expert group created
a list of International Classification
of Diseases, Ninth Revision (ICD-9)
diagnosis codes that would help
identify patients with probable
genetic disorders to be entered into a
practice registry, and also provided a
shorter list of genetic disorders that
have existing disorder-specific health
supervision guidelines or require
an emergency plan (Supplemental
Information). These lists were
only used to define the inclusion
criteria for the 7 aims related to the
management of children with genetic
disorders. Practices were encouraged
to use these complete lists but were
able to create local versions more
pertinent to their clinic setting. Once
created, practices used these registry
lists to identify patients with genetic
disorders and then reported on the
number of these patients who met
QIC aims monthly, regardless if
they were seen in the practice that
month. Practices were asked to selfidentify, in conjunction with RC input,
patients who required palliative care
discussions. Given the challenges
practices faced in working on 11 aims
simultaneously, they were surveyed
at the conclusion of the active
improvement period regarding how
hard they worked to improve each of
the 11 aims (“a lot,” “a little,” or “did
not work on”).
Finally, in an effort to expand
quantitative findings and gain
deeper insights into each practice’s
learning and implementation

process, a qualitative component
was included in the study to reflect a
mixed-methods design. Researchers
conducted semistructured exit
interviews of all participating
practices in the spring of 2014 by
using an interview protocol that
targeted questions on changes made
and sustained, characteristics leading
to success, barriers to change, and
ability to spread improvements.
These interviews were conducted
by 2 trained qualitative researchers
via telephone, lasted ~45 minutes
each, notes were typed in real time,
and participants were given the
discussion guide in advance.

Statistical Analysis
The unit of analysis was the
patient visit for aims related to the
diagnosis of children with genetic
disorders, and the unit of analysis
was the patient for aims related
to management of children with
genetic disorders. Throughout the
article, a patient’s “record” refers to
paper and electronic documentation
at a specific visit for the diagnosis
aims, and all paper and electronic
documentation for the management
aims. Due to concerns that analyzing
results from aims with minimal data
submission would lead to inaccurate
conclusions, we did not analyze aims
that in aggregate had a median of
less than 5 records submitted per
practice per month (N = 4). This
was a posthoc decision made during
data analysis. Adherence to the aim
was expressed as an indicator that
the patient record achieved the aim.
For each practice and month, we
aggregated the patient visit or patient
data and calculated the number of
patient records achieving the aim
(binomial numerator) out of the total
number of patient records reviewed
(binomial denominator). Random
intercept binomial regression
models where then used to model
the monthly adherence over time.
Defining our outcome in this way
accounted for variation over time
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and across practices in the number of
records reviewed. We hypothesized
a priori that percent adherence
with each aim would increase over
time during the active improvement
period and would potentially
continue to improve after the
conclusion of the active improvement
period; this was accounted for in the
model by including a linear spline
with a knot at the last month of
the active period. Models took into
account the potential correlations of
patient measures within practices
by including practice level random
intercepts. From the fit of the model,
monthly adherence was estimated
and Wald’s tests were used to
compare adherence at baseline to
adherence at the end of the active
improvement period (6 months)
to test for effectiveness of the QIC.
Adherence at the end of the active
improvement period was also
compared with adherence at the
end of the sustainability period (12
months) to test for sustainability. For
the 5 aims related to management,
we acknowledge that these data
denominators use nonindependent
lists of patients from month to month.
The analysis accounts for clustering
among patient visits at the same
practice, but does not account for the
potential that additional correlation
may exist for patients with multiple
visits. A sensitivity analysis was
performed for each model including
a variable for how “hard” a practice
worked on a given aim. Missing
data were assumed to be missing at
random and our methods are valid
under this assumption. Qualitative
data were analyzed by using thematic
analysis. Themes and patterns from
each interview were extracted into
main themes for a given topic across
all practice responses. Particular
attention was paid to affordances
and constraints within the change
process and extrapolations for other
quality improvement efforts. No
additional qualitative software was
employed.

TABLE 2 Demographics of 13 Participating QuIIN Practices
Characteristic

N (% or IQR)

Statesa

Practice location in the United
Northeast
South
Midwest
West
Practice setting
Suburban
Urban, noninner city
Urban, inner city
Practice type
Independent practice
Afﬁliated with a university or medical school
Afﬁliated with a hospital
County public health department/clinic
Approximate distance to nearest geneticist
5 miles or less
6–10 miles
11–30 miles
31–49 miles
50 miles or more
Median number of physicians or physician extenders seeing patients (IQR)
Practice includes residents
Practice includes family physicians
Practice uses electronic health record
eClinicalWorksa
Epic
Allscripts
Athenahealth
Cerner
Greenway Health
MediTouch
SmartClinic
Vitera
Practice sees 5000 or more patients annually
Race/ethnicity of patients, median (IQR)
White, non-Hispanic/Latino
Hispanic/Latino
African American
Asian American
Native Hawaiian/other Paciﬁc Islander
American Indian/Alaska Native
Other
Insurance status of patients, median (IQR)
Private
Public
Uninsured
Team’s knowledge of the model for improvementa
Very knowledgeable
Knowledgeable
Somewhat knowledgeable
Not knowledgeable

4 (31)
5 (38)
2 (15)
2 (15)
6 (46)
4 (31)
3 (23)
9 (69)
2 (15)
1 (8)
1 (8)
3 (23)
4 (31)
4 (31)
—
2 (15)
10 (8–13)
4 (31)
1 (8)
13 (100)
4 (31)
2 (15)
1 (8)
1 (8)
1 (8)
1 (8)
1 (8)
1 (8)
1 (8)
12 (92)
60 (30–65)
10 (5–30)
20 (5–25)
3 (2–5)
0 (0–0.1)
0 (0–0)
0 (0–1)
54 (20–65)
45 (30–80)
4 (1–5)
2 (15)
5 (38)
3 (23)
3 (23)

IQR, interquartile range.
a Total percent does not equal 100 because of rounding.

RESULTS
Twelve pediatric practices and
1 family medicine practice in 11
states serving ~130 000 pediatric
patients annually participated in
the QIC. Practice demographics are

presented in Table 2. The
QIC had representation from
large and small practices,
urban and suburban practices,
and practices with and without
previous quality improvement
knowledge.
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TABLE 3 Percent Adherence With Aims Using Random Intercept Binomial Regression Models
Aim

Diagnosis of children with genetic disorders
Family histories are created/maintained at health supervision visits
documenting all components
Current family histories are discussed with patient/family, both
positives and negatives
Management of children with genetic disorders
Patients with genetic disorders have up to date age-appropriate
health supervision visits
Patients with speciﬁc genetic disorders that have existing disorderspeciﬁc health supervision guidelines receive the speciﬁed
care16–24
Patients with genetic disorders have next steps of care and planned
follow-up
Patients with genetic disorders are offered genetic services at least
initially
Patients with genetic disorders older than 11 y old receive
resources and discussion about transition to adult care at least
annually

Baseline,
Percent
Adherence,
(95% CI)

6 Months
(End of Active
Period),
Percent
Adherence,
(95% CI)

Baseline
Versus 6
Months,
Wald’s
Test, P

12 Months
(Sustainability
Period), Percent
Adherence, (95% CI)

6 Months
Versus 12
Months,
Wald’s Test, P

6% (2–16)

60% (32–83)

<.001

80% (52–93)

.007

78% (67–86)

80% (70–88)

.51

75% (60–86)

.3

70% (58–79)

77% (67–85)

<.001

89% (83–93)

<.001

58% (23–81)

85% (72–92)

<.001

99% (97–100)

<.001

14% (3–44)

47% (15–81)

<.001

76% (39–94)

<.001

38% (16–66)

18% (9–41)

<.001

36% (15–64)

<.001

4% (1–17)

5% (1–17)

.46

7% (2–17)

.006

CI, conﬁdence interval

There was appreciable variability
in the number of records reviewed
for adherence and patients included
in registries per practice per month
(Table 1). Four aims were excluded
from analysis because the median
number of records reviewed or
patients included in registries per
practice per month were less than
5 (these analyses are available
upon request). For the 2 analyzed
aims related to the diagnosis of
children with genetic disorders,
median records reviewed ranged
from 9 to 10 per practice per month.
For the 5 analyzed aims related to
the management of children with
genetic disorders, median patients in
practice registries ranged from 16 to
94.5 per practice per month (Table
1). The median number of patients
in practice registries is particularly
variable because not all patients
with genetic disorders had health
supervision guidelines or required
transition of care discussions. Three
teams did not submit sustainability
data.
Adherence with 4 of the 7 aims had
significant improvements comparing

baseline to the end of the active
improvement period using the fit
of the random intercept binomial
regression models: “family histories
are created/maintained at health
supervision visits documenting all
components” (6% vs 60%, P < .001),
“patients with genetic disorders
have up to date age-appropriate
health supervision visits” (70%
vs 77%, P < .001), “patients with
specific genetic disorders that have
existing disorder-specific health
supervision guidelines16–24 receive
the specified care” (58% vs 85%, P
< .001), and “patients with genetic
disorders have next steps of care
and planned follow-up” (14% vs
47%, P < .001; Table 3). All of these
aims also demonstrated statistically
significant improvements in
adherence using the fit of the random
intercept binomial regression models
comparing the end of the active
improvement period to the end of
the sustainability period, suggesting
improvements were sustained
and even increased. Numerical
improvements in adherence for 2
other aims did not reach statistical
significance comparing baseline to

the end of the active improvement
period. Contrary to our hypothesis,
1 aim demonstrated a statistically
significant reduction in adherence
with the aim comparing baseline to
the end of the active improvement
period: “patients with genetic
disorders are offered genetic services
at least initially” (38% vs 18%, P <
.001).
The 2 aims with the highest percent
of practices reporting they worked a
lot on the aim were family histories
are created/maintained at health
supervision visits documenting all
components, (85% worked on a lot)
and patients with genetic disorders
have up to date age-appropriate
health supervision visits (62%
worked on a lot). On the contrary,
the 2 aims with the highest percent
of practices reporting they did not
work on the aims were “patients
with genetic disorders who require
an emergency plan to prevent
catastrophic illness have a plan
requested from the specialist and
placed in the chart, at least annually”
(46% did not work on), and “patients
with genetic disorders have a
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discussion about palliative care at
least annually when appropriate”
(46% did not work on). Both of these
aims had less than 5 median records
submitted per practice per month.
Including the variable for how hard a
practice worked on a given aim, did
not appreciably change the effect size
or statistical significance for any aim.
Qualitative exit interviews of
participating practices suggested
4 key learning points: (1) practice
commitment to change, buy-in
from staff, and having a champion
for change were the most noted
characteristics contributing to the
success of project implementation,
and when 1 of these facets were
missing, change was more difficult
to implement; (2) although practices
noted barriers to change and that
the project required a great deal of
work, most indicated they would
encourage other practices to pursue
these changes; (3) participation
helped practices “think genetically,”
which increased the identification
of patients with genetic disorders
and improved the quality of patient
care; and (4) electronic health
record systems were limited in their
ability to incorporate family history
information.

DISCUSSION
This national QIC in 13 pediatric
and family medicine primary care
practices demonstrated statistically
significant improvement in 4 of 7
process aims related to the diagnosis
and management of children with
genetic disorders. Moreover, all 4
of these aims revealed sustained
improvement 6 months after the
conclusion of the QIC. Primary
care practices, ranging from rural,
private-practice single practitioner
sites to urban, university affiliated
multipractitioner tertiary care clinics,
were able to share, collaborate, and
work to improve genetic-related care
for their patients and families.

Pediatricians are tasked with
diagnosing and managing an
increasing array of patients during
shorter appointment times. QIC
projects can help busy ambulatory
practices deliver best-practice care
for all patients and speed adoption of
health supervision guidelines.28 By
identifying gaps in current patient
care processes,7 and then using “all
teach, all learn” methodologies, this
QIC improved the care delivered to
patients. A toolkit derived from this
collaborative learning process is
available for download.36 Interested
providers should examine this
toolkit that provides step-by-step
instructions for achieving these aims
and lessons learned from this QIC.
These data suggest any primary
care practice, regardless of setting,
patient demographics, or patient
volume, can augment existing genetic
health care services. Also, these data
suggest that genetic care may not be
different from other pediatric care
processes, which can be improved
with local, context-specific resources,
sharing challenges and successes
with like-minded practices, and QIC
methodology.
It is unclear why some aims were
more successfully implemented than
others during this QIC, with 1 aim
demonstrating a decreased percent
of records achieving the aim. It is
possible that these aims were more
difficult to implement, not as much
of a priority for practices, or more
challenging to measure. The authors
also hypothesize that simultaneously
presenting 11 aims for improving
care, although comprehensive, posed
too demanding a task for practices
over the 6-month time period
allotted. It is unclear why adherence
with the aim of patients with genetic
disorders are offered genetic services
at least initially decreased from
baseline to 6 months (38%–18%, P
< .001) but statistically significantly
improved from 6 months to 12
months (18%–36%, P < .001). We
hypothesize that practices’ increased

focus on providing other genetic
services reduced their focus on the
offering of genetic services or its
documentation, leading to an initial
reduction with eventual rebound
when practices were more familiar
with other genetic services. Based
on exit interview results, the authors
note similarities between reported
markers of success in this project
and previous models of quality
improvement success.37 Additionally,
we suggest effort is needed to
improve electronic health record
family history taking, with a focus on
family participation in building the
family history and the tools used to
collect it.
Over the past decade, the traditional
notion of genetic disorders as rare
entities has undergone a significant
shift toward the realization that in
the aggregate genetic conditions are
common. Although individually rare,
a growing number of more than 4200
disorders are known to be caused by
alterations of single genes.38 Recent
evidence suggests that individuals in
the general population may carry an
average of 3 recessive mutations for
childhood disease.39 Approximately
2% to 3% of newborns are affected
by major congenital anomalies
that collectively account for ~20%
of deaths in infancy, another 5%
to 6% of the population will be
diagnosed with a genetic condition
by early adulthood, and up to
one third of the population will
develop a condition with a genetic
component by age 60.40 It is in this
context that pediatricians are faced
with the challenging responsibility
of integrating rapidly expanding
resources for genetic medicine into
diagnosis and care management.
For practitioners to take part in the
evolving translation of genomics
into clinical medicine, core
competencies need to be developed
and implemented into a practice flow.
This QIC was an attempt to develop
a guiding framework for process
changes aimed at improving the care
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of patients with genetic disorders
in the setting of busy primary
care practices. The 2 domains of
improvement focused on during the
project, diagnosis and management,
reflect previously proposed genomic
competencies for primary care
providers,41 including evaluation and
diagnosis, genetic testing and risk
communication, and management
and coordination of care. These data
could help to prioritize benchmarks
for quality care delivered to children
with these disorders.
We acknowledge limitations in this
research design. First, data were
collected and submitted by practices
without systematic, centralized data
checking for appropriate coding. We
created multiple opportunities for
practices to learn and re-learn about
data collection and QIC measure
definitions at learning sessions and
webinars. Although obvious errors
in rates or numbers entered were
brought to practices’ attention, we
cannot speak comprehensively to
data accuracy. Similarly, for aims
related to the management of
children with genetic disorders,
practices were allowed to create
their own lists of patients included
in a registry and it is unclear how
consistent these denominator
definitions were applied across sites.
Related to this, some measures had
few practices reporting patients
meeting criteria for inclusion in the
denominator, leading to process
measures with variable numbers
of data points and the exclusion
of 4 aims with less than 5 median
records submitted per practice per
month. Questions to practices on
how hard they worked on each aim
were not validated and may not
reflect the quality of care received

by patients. This is exemplified by
1 practice’s qualitative response
that, “The items we did not work
on were either already in place or
not relevant to our patients.” This
could explain why this variable did
not appreciably change model effect
sizes or statistical significance in the
sensitivity analyses. Three practices
did not submit sustainability data at
the 12-month time point. It is unclear
if data from these practices would
have decreased the number of aims
demonstrating sustainability. The
practices included in this project
were self-selected by interest in
the topic and interest in quality
improvement in general. The
results obtained therefore, may
be more challenging to generalize
to practices without genetic and/
or quality improvement interest.
Despite this, we believe having
motivated, “innovator” practices
test, develop and demonstrate what
is possible in quality improvement,
allows other pediatric practices
to more quickly adopt and adapt
important quality improvement
interventions. Six of the 13 practices
reported they were “somewhat”
or “not knowledgeable” about the
Model for Improvement, suggesting
that previous quality improvement
experience may not be a prerequisite
to complete similar projects. Finally,
observed, nonaggregated data from
practices demonstrate continued
local variability in process measures,
suggesting practices could still
improve and these data may not
represent a true benchmark for what
is possible.

CONCLUSIONS
A national QIC reveals promise
in improving process measures

related to the diagnosis and
management of children with genetic
disorders in primary care settings.
Future research should focus on
sustainability of interventions
past 12 months, patient outcome
measures, the applicability of lessons
learned through dissemination
of the QICs genetic toolbox,36 and
the optimal number of aims to
simultaneously pursue in QICs.
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